Literature DB >> 8112739

Evidence for genetic heterogeneity underlying hereditary neuropathy with liability to pressure palsies.

E C Mariman1, A A Gabreëls-Festen, S E van Beersum, P J Jongen, E van de Looij, F Baas, P A Bolhuis, H H Ropers, F J Gabreëls.   

Abstract

Hereditary neuropathy with liability to pressure palsies (HNPP) is a disorder of the peripheral nervous system, the cause of which has recently been identified as a deletion on chromosome 17p. The deletion corresponds to the duplication that is commonly observed in patients with hereditary motor and sensory neuropathy type Ia (HMSNIa, 17p11.2-p12). Therefore, the gene for peripheral myelin protein 22 (PMP-22) is a candidate gene for both HMSNIa and HNPP. Here, we show that a similar deletion is present in one family with HNPP but is clearly absent in another family. Affected members of this family carry the expected two copies of the PMP-22 gene and the surrounding region. Furthermore, linkage analyses of this family exclude a large part of 17p, spanning the area deleted in other families with HNPP, as the location for the disease gene. These data strongly argue for the existence of genetic heterogeneity underlying HNPP. Results from two-point linkage analysis with markers on chromosome 1q are inconsistent with a possible involvement of the locus for HMSNIb in the present family.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8112739     DOI: 10.1007/bf00210601

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  21 in total

Review 1.  Report of the committee on the genetic constitution of chromosome 17.

Authors:  E Solomon; D H Ledbetter
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Dinucleotide repeat polymorphism at the D1S117 locus.

Authors:  V Sharma; M Litt
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

3.  Dinucleotide repeat polymorphism at the CRP locus.

Authors:  J L Weber; A E Kwitek; P E May
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

4.  Dinucleotide repeat polymorphism at the D1S104 locus.

Authors:  J L Weber; A E Kwitek; P E May
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

5.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

6.  A genetic map of human chromosome 17p.

Authors:  E C Wright; D E Goldgar; P R Fain; D F Barker; M H Skolnick
Journal:  Genomics       Date:  1990-05       Impact factor: 5.736

7.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

8.  Gene for hereditary neuropathy with liability to pressure palsies (HNPP) maps to chromosome 17 at or close to the locus for HMSN type 1.

Authors:  E C Mariman; A A Gabreëls-Festen; S E van Beersum; P J Jongen; H H Ropers; F J Gabreëls
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

9.  Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A.

Authors:  L J Valentijn; F Baas; R A Wolterman; J E Hoogendijk; N H van den Bosch; I Zorn; A W Gabreëls-Festen; M de Visser; P A Bolhuis
Journal:  Nat Genet       Date:  1992-12       Impact factor: 38.330

10.  The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A.

Authors:  P I Patel; B B Roa; A A Welcher; R Schoener-Scott; B J Trask; L Pentao; G J Snipes; C A Garcia; U Francke; E M Shooter; J R Lupski; U Suter
Journal:  Nat Genet       Date:  1992-06       Impact factor: 38.330

View more
  8 in total

1.  Hereditary neuropathy with liability to pressure palsies with a partial deletion of the region often duplicated in Charcot-Marie-Tooth disease, type 1A.

Authors:  F Chapon; P Diraison; B Lechevalier; G Chazot; F Viader; C Bonnebouche; A Vandenberghe; V Timmerman; C Van Broeckhoven; A Vandenberghe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

Review 2.  Animal models for inherited peripheral neuropathies.

Authors:  R Martini
Journal:  J Anat       Date:  1997-10       Impact factor: 2.610

3.  Atypical hereditary neuropathy with liability to pressure palsies (HNPP): the value of direct DNA diagnosis.

Authors:  M Sessa; R Nemni; A Quattrini; U Del Carro; L Wrabetz; N Canal
Journal:  J Med Genet       Date:  1997-11       Impact factor: 6.318

Review 4.  Molecular anatomy and genetics of myelin proteins in the peripheral nervous system.

Authors:  G J Snipes; U Suter
Journal:  J Anat       Date:  1995-06       Impact factor: 2.610

5.  Molecular genetic analysis of the 17p11.2 region in patients with hereditary neuropathy with liability to pressure palsies (HNPP).

Authors:  V Timmerman; A Löfgren; E Le Guern; P Liang; P De Jonghe; J J Martin; D Verhalle; W Robberecht; R Gouider; A Brice; C Van Broeckhoven
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

6.  Clinical and Molecular Characterization of PMP22 point mutations in Taiwanese patients with Inherited Neuropathy.

Authors:  Yi-Chu Liao; Pei-Chien Tsai; Thy-Sheng Lin; Cheng-Tsung Hsiao; Nai-Chen Chao; Kon-Ping Lin; Yi-Chung Lee
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

7.  Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients.

Authors:  P Mandich; R James; S Nassani; R Defferrari; E Bellone; G Mancardi; A Schenone; M Abbruzzese; M Rocchi; F Ajmar
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

8.  A 1.5-Mb deletion in 17p11.2-p12 is frequently observed in Italian families with hereditary neuropathy with liability to pressure palsies.

Authors:  D Lorenzetti; D Pareyson; A Sghirlanzoni; B B Roa; N E Abbas; M Pandolfo; S Di Donato; J R Lupski
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.